BOS Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
BOS Asset Management's ABBV Position: Q2 2026 in Review
BOS Asset Management reduced its AbbVie (ABBV) stake by 7.6% in Q2 2026, selling an estimated $15.3K and leaving 862 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #188.
BOS Asset Management first reported a position in ABBV in Q3 2024 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- BOS Asset Management held 862 shares of AbbVie worth $217K as of Q2 2026.
- BOS Asset Management sold 71 AbbVie shares in Q2 2026, an estimated $15.3K.
- AbbVie made up 0.05% of BOS Asset Management's portfolio in Q2 2026, its #188 holding.
- BOS Asset Management first reported a position in AbbVie in Q3 2024 and has held it in 4 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on BOS Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.